Karen S. Lynch is President and Chief Executive Officer of CVS Health, a Fortune 4 diversified health services company. Karen leads more than 300,000 colleagues who are passionate about transforming health care to be simpler, more convenient and more personalized.
Under Karen’s leadership, CVS Health touches the lives of more than 100 million people each year through its unique combination of assets, including more than 9,900 pharmacies and over 1,000 MinuteClinic and HealthHUB locations. CVS Health also serves an estimated 34 million people through its health insurance products and services. CVS Health continues to play a leading role in the national response to COVID-19 through testing solutions and vaccine administration across the country.
Karen has over three decades of experience in the health care industry. Prior to becoming Chief Executive Officer, she was Executive Vice President, CVS Health and President of Aetna and responsible for driving the strategy to deliver consumer-focused, high-value health care to the millions of people Aetna serves.
Before joining CVS Health, Karen held executive positions at Cigna and Magellan Health Services, where she served as president. She began her career with Ernst & Young as a Certified Public Accountant (CPA).
In 2021, she was included on Forbes’ inaugural “50 over 50” list. She was recognized by Forbes as one of The World’s 100 Most Powerful Women in 2020 and included on Business Insider’s Top 100 People Transforming Business list in 2019. For the past five years (2016 to 2020), she was named to Fortune’s list of the 50 Most Powerful Women in Business.
Karen is a trustee of The Bushnell Performing Arts Center and a member of the Global 50 and the Boston College Women’s Council. She also serves as a member of the Business Roundtable.
A graduate of Boston College and The Questrom School of Business at Boston University, Karen was awarded an honorary doctorate of humane letters from Becker College in 2015.
What is Karen S. Lynch's net worth?
The estimated net worth of Karen S. Lynch is at least $25.48 million as of May 3rd, 2023. Ms. Lynch owns 431,392 shares of CVS Health stock worth more than $25,482,325 as of December 3rd. This net worth approximation does not reflect any other investments that Ms. Lynch may own. Additionally, Ms. Lynch receives a salary of $5,120,000.00 as EVP at CVS Health. Learn More about Karen S. Lynch's net worth.
How old is Karen S. Lynch?
What is Karen S. Lynch's salary?
How do I contact Karen S. Lynch?
Has Karen S. Lynch been buying or selling shares of CVS Health?
Karen S. Lynch has not been actively trading shares of CVS Health during the last ninety days. Most recently, on Wednesday, May 3rd, Karen S. Lynch bought 14,000 shares of CVS Health stock. The stock was acquired at an average cost of $69.75 per share, with a total value of $976,500.00. Following the completion of the transaction, the chief executive officer now directly owns 431,392 shares of the company's stock, valued at $30,089,592. Learn More on Karen S. Lynch's trading history.
Who are CVS Health's active insiders?
CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?
In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $53,880.00. In the last twelve months, insiders at the pharmacy operator sold shares 1 times. They sold a total of 29,473 shares worth more than $2,267,947.35. The most recent insider tranaction occured on May, 2nd when Director Edward J Ludwig bought 1,000 shares worth more than $53,880.00. Insiders at CVS Health own 0.2% of the company.
Learn More about insider trades at CVS Health. Information on this page was last updated on 5/2/2024.
